Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies. Its mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development.
|Employees (est.) (Oct 2019)||14||(-6%)|
Envisagenics total Funding
Envisagenics latest funding size
Time since last funding
|2 years ago|
|SV Angel, Shana Fisher, Dolby Family Ventures, National Institutes of Health, Grand Central Tech, Third Kind Venture Capital, The Thiel Foundation, Accelerate Long Island, the Long Island Emerging technologies Fund (LIETF), Dynamk Capital, Empire State Development, Cosine, Gillian Sandler, Daniella Kranjac|
Envisagenics has 791 Twitter Followers. The number of followers has increased 1.4% month over month and increased 3% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Envisagenics founded?
Envisagenics was founded in 2014.
Who are Envisagenics key executives?
Envisagenics's key executives are Maria Luisa Pineda and Martin Akerman.
How many employees does Envisagenics have?
Envisagenics has 14 employees.
Who are Envisagenics competitors?
Competitors of Envisagenics include Desktop Genetics, Mologic and Avidity Biosciences.
Where is Envisagenics headquarters?
Envisagenics headquarters is located at Huntington, NY, USA, Huntington.
Where are Envisagenics offices?
Envisagenics has an office in Huntington.
How many offices does Envisagenics have?
Envisagenics has 1 office.
Receive alerts for 300+ data fields across thousands of companies